Gilead Sciences Update on Supply and Distribution of Veklury (remdesivir) in the United States

FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 1, 2020-- Since the COVID-19 pandemic began, Gilead has worked diligently to ramp up production and rapidly expand the supply of our investigational antiviral drug Veklury® (remdesivir) by making...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials